GREY:IMVIF - Post by User
Comment by
Hideawayon Dec 14, 2018 12:17pm
93 Views
Post# 29116434
RE:I thought I was being patient (sort of) but jeez...
RE:I thought I was being patient (sort of) but jeez...Day traders must be having a ball with IMV when we have daily moves of 2% to 9%. This is not likely to stop until we get more positive results from the Merck trials. This is what,IMHO, will spur management on to do the US financing. I do not think the upcoming FDA meeting will the timing they are seeking.We may get a bump up following the FDA approval to proceed but I would not be suprised to see the same trading patterns persist until a bit more definition comes from Merck.We also have experienced very encouraging results to date and any negativity from upcoming trials would really hurt. The biotec sector can be ruthless for shareholders if results do not meet expectations. One can become to emotionally involved with a stock and that can lead to substantial losses. I must admit that with IMV I am somewhat over-invested because the science is so compelling to date. I hope fot the sake of all longs the ride continues. First half of 2019 should provide us with much more clarity.
GLTA